Aeolus Pharmaceuticals, Inc. Stock Other OTC
Equities
AOLS
US00765G1094
Biotechnology & Medical Research
Sales 2015 | 3.11M 4.27M | Sales 2016 | 2.08M 2.85M | Capitalization | 28.9M 39.65M |
---|---|---|---|---|---|
Net income 2015 | -2M -2.74M | Net income 2016 | -3M -4.12M | EV / Sales 2015 | 10.8 x |
Net Debt 2015 | 908K 1.25M | Net cash position 2016 | 3.16M 4.33M | EV / Sales 2016 | 12.4 x |
P/E ratio 2015 |
-12
x | P/E ratio 2016 |
-4.67
x | Employees | - |
Yield 2015 * |
-
| Yield 2016 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
John McManus
CEO | Chief Executive Officer | 60 | 05-05-31 |
David Cavalier
CHM | Chairman | 54 | 04-04-29 |
Members of the board | Title | Age | Since |
---|---|---|---|
David Cavalier
CHM | Chairman | 54 | 04-04-29 |
Jeffrey Scott
BRD | Director/Board Member | 67 | 13-05-07 |
John Clerici
BRD | Director/Board Member | 54 | 13-05-07 |
1st Jan change | Capi. | |
---|---|---|
+0.67% | 42.4B | |
+46.51% | 40.04B | |
-6.20% | 28.31B | |
+6.55% | 24.94B | |
-21.66% | 18.96B | |
+29.96% | 12.3B | |
-1.57% | 11.95B | |
+16.03% | 11.32B | |
-4.80% | 11.55B |